ripekg:evaluation/RIPEA4875E56C8C5C4ACF |
prov:wasInformedBy |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |
rdf:type |
rdfs:Resource |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |
rdf:type |
owl:Thing |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |
rdf:type |
ripe:EvidenceAggregationEvidence aggregation |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |
rdf:type |
tido:Activity |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |
prov:startedAtTime |
2026-03-04T14:14:31.766078Z |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEA4875E56C8C5C4ACF |
ripekg:publication-details/RIPEA4875E56C8C5C4ACFChanges in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |
ripekg:registry-evidence/RIPEA4875E56C8C5C4ACF |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |
ripekg:retraction-notice/19710Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |
ripekg:study-design-evidence/RIPEA4875E56C8C5C4ACF |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4875E56C8C5C4ACF |